European Stakeholder Learnings Regarding Biosimilars: Part I—Improving Biosimilar Understanding and Adoption

BACKGROUND: Despite the benefits offered by biosimilars in terms of cost savings and improved patient access to biological therapies, and an established regulatory pathway in Europe, biosimilar adoption is challenged by a lack of knowledge and understanding among stakeholders such as healthcare prof...

Descripción completa

Detalles Bibliográficos
Autores principales: Barbier, Liese, Simoens, Steven, Vulto, Arnold G., Huys, Isabelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7669769/
https://www.ncbi.nlm.nih.gov/pubmed/33141421
http://dx.doi.org/10.1007/s40259-020-00452-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7669769/
https://www.ncbi.nlm.nih.gov/pubmed/33141421
http://dx.doi.org/10.1007/s40259-020-00452-9

Ejemplares similares